Crypto is continuing its bull run at the start of what has been dubbed "Crypto Week" in Washington, where the House of Representatives will consider three bills with the potential to overhaul U.S.

At first glance, that might look like a red flag for the market's record-setting run, because small caps and discretionary stocks usually participate in a strong market rally when the economy is on ...

The 2-year yield declined 0.017 percentage point to 3.896% today. The price rose 1/32 to 99 23/32. --Yield is off 0.625 percentage point from its 52-week high of 4.521% hit Monday, July 22, 2024 ...

The 30-year yield rose 0.014 percentage point to 4.971% today. The price fell 7/32 to 96 18/32. --Yield is off 0.118 percentage point from its 52-week high of 5.089% hit Wednesday, May 21, 2025 ...

MicroStrategy's stock surged 4% in morning trading toward its second-highest closing price, behind only its record close of $473.83, reached on Nov. 20, 2024. The stock subsequently pared its gains ...

With home sales sluggish, and home building and house prices poised to plummet too, Mark Zandi, chief economist of Moody's Analytics, says he's sending up a "red flare" about the state of the housing ...

--Corn for December delivery rose 1.5% to $4.18 1/2 a bushel on the Chicago Board of Trade on Monday, with traders opting to cover short positions in corn and take advantage of the most-active ...

Value stocks will outperform growth stocks in coming months if inflation heats up.

Starbucks Tells White-Collar Workers to Come to the Office More-Or Take a Buyout The four-day minimum requirement will begin in the new fiscal year, and some leaders will have to relocate to Seattle ...

The Canadian dollar slipped lower on Monday afternoon with the loonie at 72.98 U.S. cents compared to Friday's close of 73.08. There were 29,028 contracts traded on Monday, compared to 43,349 on ...

Replacing Tim Cook as Apple's (AAPL) chief executive, an idea that is growing in some corners of the financial world, seems like a bad idea.

However, Waters has announced plans to merge with BD's life science and diagnostics segment in early 2026, which will dilute that interest in that highly regulated end market, going forward. The ...